Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: Kratom, a Southeast Asian plant with opioid-receptor mediated effects, has emerged as a potential substance of abuse, with limited data on its use and effects. This study characterized kratom user demographics, use patterns, and perceived drug effects. Methods: A cross-sectional, anonymous online survey was conducted between January and December 2017. Results: 2,798 kratom users – mean age 40 (SD=12); predominantly White (90%), female (61%), and located in the US (97%) – completed the survey. Kratom was primarily taken orally in doses of 1-3 grams (49%), with daily use (59%) being most common. Kratom was used for pain (91%), anxiety (67%), and depression (65%), with high ratings of effectiveness. 1,144 (41%) used kratom to stop or reduce prescription or illicit opioid use, citing decreased opioid withdrawal and craving related to kratom use, with 411 reporting >1-year continuous abstinence from opioids attributed to kratom use. Roughly one-third of respondents reported adverse effects of kratom, largely rated as mild in severity and lasting ≤24 hours. Seventeen participants (0.6%) sought treatment for adverse effects. Fifty-six individuals (2%) met DSM-5 criteria for a past-year moderate or severe kratom-related substance use disorder (SUD). When asked how troubled they felt regarding their kratom use, the mean (SD) rating was 3.2 (9.8) on a scale from 0 to 100. Conclusion: Kratom is used among White, middle-aged Americans for symptoms of pain, anxiety, depression, and opioid withdrawal. Although regular use was typical, kratom-related SUD and serious adverse effects were uncommon. Additional research on kratom epidemiology and pharmacology is imperative in light of the present opioid epidemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hays, R. D., Bjorner, J. B., Revicki, D. A., Spritzer, K. L., & Cella, D. (2009) · Quality of Life Research · doi:10.1007/s11136-009-9496-9 · Cited by 1,957 · cited 1×
“below US general population means (Hays et al., 2009), though lifetime pain and depression diagnoses were highly prevalent among respondents.”
BackgroundIncreases in drug and opioid overdose deaths — United States, 2000–2014
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6450a3 · Cited by 1,859
Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0211 · Cited by 934 · cited 1×
“These findings are congruent with observed comorbidity between opioid use disorder, pain, and psychiatric conditions such as depression (Conway et al., 2006; Fischer et al., 2012).”
BackgroundSelf‐treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)
Boyer, E. W., Babu, K. M., Adkins, J. E., McCurdy, C. R., & Halpern, J. H. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02209.x · Cited by 343
The drug effects questionnaire: psychometric support across three drug types
Morean, M. E., de Wit, H., King, A. C., Sofuoglu, M., Rueger, S. Y., & O’Malley, S. S. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2954-z · Cited by 252
Advances in Patient Reported Outcomes: The NIH PROMIS Measures
Broderick, J., DeWit, E. M., Rothrock, N., Crane, P., & Forrest, C. B. (2013) · eGEMs (Generating Evidence & Methods to improve patient outcomes) · doi:10.13063/2327-9214.1015 · Cited by 244
Cited by
Ahmad, J., Odin, J. A., Hayashi, P. H., Fontana, R. J., Conjeevaram, H., Avula, B., Khan, I. A., Barnhart, H., Vuppalanchi, R., & Navarro, V. J. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108426 · Cited by 33
Metadata
- Authors
- Garcia-Romeu, A., Cox, D. J., Smith, K. E., Dunn, K. E., & Griffiths, R. R.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 208
- Pages
- 107849
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W3004192768
- Cited by
- 184
- References
- 6
- FWCI
- 19.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2020.107849
- The paper
- Garcia-Romeu, A., Cox, D. J., Smith, K. E., Dunn, K. E., & Griffiths, R. R. (2020). Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2020.107849
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.